DestinationRx, Inc. (DRX) is a Los Angeles-based leading provider of technology solutions for web-based prescription drug companies as well as Medicare health plan comparison and enrollment services. DRX’s clients include federal and local governments and some of the largest health plans in the United States. DRX was a privately-held, venture backed company.
In 2008, DRX undertook a venture capital led Series A financing and asked Maslon’s Doug Holod to serve as their corporate counsel. Since that time, Doug has led a team of Maslon attorneys, including Alan Gilbert, Shauro Bagchi, and Kathleen Crowe, to provide corporate governance, contract, securities and compensation, employment, insurance-related, litigation, other technology, trademark, and real estate services to DRX.
Working with a major health care investment banking firm, Doug led the legal team involved with DestinationRX’s merger with another health care technology company that closed in early 2013. While the terms of the transaction cannot be publically disclosed, the Maslon team worked on negotiating all legal aspects of the transaction such as the Letter of Intent, the Merger Agreement and related agreements.